- Home
- NVO vs UBS Comparison
NVO vs UBS Comparison
Compare NVO & UBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVO | UBS |
|---|---|---|
| Founded | 1923 | 1862 |
| Country | Denmark | Switzerland |
| Employees | 69500 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.1B | 135.5B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | NVO | UBS |
|---|---|---|
| Price | $41.31 | $42.01 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 2 |
| Target Price | $51.00 | ★ $60.30 |
| AVG Volume (30 Days) | ★ 13.6M | 2.4M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.12% | 1.33% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.40 |
| Revenue Next Year | $3.70 | $2.83 |
| P/E Ratio | ★ $13.60 | $17.22 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $35.12 | $29.73 |
| 52 Week High | $81.44 | $49.36 |
Technical Indicators
Market Signals| Indicator | NVO | UBS |
|---|---|---|
| Relative Strength Index (RSI) | 60.76 | 54.98 |
| Support Level | $35.49 | $41.24 |
| Resistance Level | $41.41 | $42.57 |
| Average True Range (ATR) | 0.98 | 0.73 |
| MACD | 0.43 | -0.03 |
| Stochastic Oscillator | 96.89 | 36.70 |
Price Performance
Historical ComparisonAbout NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About UBS UBS Group AG Registered
UBS is a global financial institution built around its core strength in wealth management, serving high and ultra-high-net-worth individuals. In Switzerland, it also operates as a traditional retail and commercial bank. Its investment bank and asset management divisions complement the wealth business, providing tailored solutions to UBS clients while serving third-party customers by leveraging UBS' global reach and expertise.